- Protocol Short Name and Number: PROGRESS V, 2503
- Protocol Long Name: A Randomized, Multicenter, Phase III Trial Comparing High Dose to Reduced-Dose Cyclophosphamide After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation
- Protocol Synopsis
- FAQs
- Key Personnel
- BMT CTN #2503 Co-Chair: Lori Muffly, MD, MS
- BMT CTN #2503 Co-Chair: Shannon McCurdy, MD,
- BMT CTN #2503 Protocol Officer: Sameem Abedin, MD
- BMT CTN #2503 Protocol Coordinator: bmtctn2503@emmes.com
Keywords: Allo HCT, PBSC, Myeloablative, Acute Leukemias, Myeloproliferative neoplasms, Resistant Potato Starch (RPS)